InvestorBrandNetwork (IBN) logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

2 Billion Pounds of Cancer-Causing Chemicals Found Their Way into America in 2020

September 30, 2026 — Chemicals suspected of raising the risk of breast cancer entered America’s air by the billions of pounds within one recent year, settling into a pattern that stretches across daily life. The exposure shows up in outdoor air, tap water, food, and the products sitting on household shelves, all traced back to the same body of research.


AINewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) QwikAgents Expands AI Platform With NVIDIA Support, Hermes Runtime

September 30, 2026 — Silo Pharma (NASDAQ: SILO) announced that its wholly owned managed AI agent subsidiary QwikAgents expanded its platform with support for customer-supplied NVIDIA API keys and the addition of Hermes agent runtime. Customers can use their own NVIDIA API keys to access NVIDIA Nemotron models, making NVIDIA the fifth supported bring-your-own-key provider alongside Anthropic, OpenAI, Google and DeepSeek.


Stocktoberfest 2026 Set to Offer Entertaining Multi-Setting Financial and Investment Conference with ‘Full Experience + Golf’ Package

September 30, 2026 — Date: October 5-7, 2026 Venue: New York City Stocktoberfest 2026 by Stocktwits goes beyond the traditional investor conference, offering a Full Experience + Golf package as one of the available options. The package combines a complete two-and-a-half-day event with an 18-hole round at the famed Century Country Club in Purchase, New York, along with the core investor event and variety of additional perks.


InvestorNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Moves VXA-222 Bispecific ADC to Next Development Stage

September 29, 2026 — VERAXA Biotech (NASDAQ: VRXA) has advanced its VXA-222 bispecific antibody-drug conjugate (“ADC”) program beyond the initial discovery phase following the completion of its collaboration with OmniAb, with the company now planning to engineer the final candidate using its antibody-engineering, linker and conjugation technologies and conduct in vitro and in vivo preclinical studies. VXA-222 employs an “AND-gate” design intended to recognize two tumor-associated antigens simultaneously, potentially increasing selectivity for cancer cells, while VERAXA continues developing a broader oncology pipeline spanning ADCs, T-cell engagers and other engineered antibody formats.


Training Decay and the Need for Continuous, Scenario-Based Readiness

September 29, 2026 — Training decay can create challenges for public safety agencies as important skills and knowledge fade when they are not regularly reinforced. Continuous training can help personnel maintain proficiency and readiness between formal certification or qualification periods.


Top Possibilities of How AI Could Hypothetically Wipe Out Humanity

September 29, 2026 — Earlier this month, AI researcher Jacob Coxon left Anthropic after spending only four months at the company. In a post on X, Coxon warned that many people developing AI genuinely believe the technology could pose an existential threat to humanity before the decade ends.


Copper Prices Seem to Be Positioning for a Significant Upswing

September 29, 2026 — The price of copper appears to be building the foundation for another potentially significant advance, with the technical picture pointing to possibly higher prices, if the metal can overcome an important resistance level. The setup begins with a notable reversal in copper’s recent price action.


Earth Science Tech Inc. (ETST) Driving Sustainable Growth on New Technologies, In-House Expertise

September 29, 2026 — Earth Science Tech is leveraging AI and other technology, along with the expertise of a focused IT department, to drive sustainable growth and ensure long-term value The company uses technology to drive down costs, improve operational efficiencies, and expand profit margins within its pharmacy and telemedicine platforms ETST also utilizes technology in marketing to increase patient and customer retention and drive brand loyalty During the recent Annual Meeting of Shareholders, CTO Chris Rose explained the company’s tech stack and developments that have enabled it to offer its in-house tools to other clinics as a white-label service Earth Science Tech (OTCQB: ETST) is a strategic holding company that brings together innovative businesses across the healthcare, pharmacy, technology and telemedicine, real estate, and consumer products spaces. The company employs a dedicated IT infrastructure department, led by Chief Technology Officer Chris Rose, that has enabled it to leverage new technology to cut costs, improve operational efficiencies, and expand profit margins across its pharmacy and telemedicine platforms.


Study Finds High-Mileage EVs More Reliable Than Gas Counterparts

September 29, 2026 — Secondhand electric vehicles with high mileage are proving more dependable than comparable gas-powered cars, according to new research examining nearly 50 million UK roadworthiness test results. Looking specifically at cars driven between 90,000 and the 120,000-mile mark, the failure rate for EVs came in at 16.